Select your country
Americas
Argentina
Brazil
Canada
Chile
Colombia
Costa Rica
Dominican Republic
Ecuador
El Salvador
Mexico
Peru
U.S.A.
Uruguay
Europe
Austria
Belgium
Croatia
Czech Republic
Denmark
Finland
France
Germany
Greece
Hungary
Ireland
Italy
Latvia
Malta
Netherlands
Norway
Poland
Portugal
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
United Kingdom
Rest of the world


Designing Innovation Around Patient Access and Responsibility. Why Early Decisions Determine Who Gets Treated
Tony Toks Akiwumi (Author) · HMD Publishing · Hardcover
Pharmaceutical innovation succeeds every day, yet patient access too often does not.
Regulatory approval is frequently treated as the finish line, but it only grants permission to market a therapy and does not guarantee that a single patient will receive it, because between approval and adoption lies a complex reality shaped by evidence, affordability, policy, and trust.
In Designing Pharmaceutical Innovation Around Patient Access and Responsibility, Tony Toks Akiwumi challenges the industry's most persistent assumption that good science naturally finds its way to patients, drawing on real world experience across development, market access, and policy to show how early decisions in trial design, evidence generation, pricing, and stakeholder engagement quietly determine who gets treated and who does not.
Introducing practical frameworks such as the Access Equation, the New Value Triangle, and the Access Maturity Matrix, the book equips organisations to move from approval first thinking to access first design, using case studies, leadership tools, and candid reflection to demonstrate how innovation can be built for adoption rather than hope.
For leaders in pharma, biotech, policy, and healthcare, this is both a strategic guide and a moral argument, grounded in a simple truth: the real measure of innovation is not what is approved, but who it ultimately reaches.
Do you have a question about the book? Login to be able to add your own question.

